CSAD and metabolic dysfunction-associated steatotic liver disease: In the present study, we found that CSAD was downregulated in NAFLD patients and model mice, and then its function was explored in vitro and in vivo, providing a clue that CSAD might be an important factor in the pathogenesis of NAFLD.